glp 1 ulcerative colitis Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology GLP-1 Receptor Agonists in Obese

FOUNTAIN OF YOUTH (GHK-Cu | BPC-157 | TB-500 | Epitalon) A regenerative peptide blend designed to support cellular renewal, tissue repair, and mitochondrial health

Older GLP-1 drugs: liraglutide, dulaglutide, exenatide, lixisenatide These earlier agents still appear on the list and remain options where cost, formulary placement, or tolerability favour them, though the trials show smaller average effects than semaglutide or tirzepatide

As CSC-targeted therapy evolves, innovative approaches have the potential to overcome therapy resistance, reduce tumor recurrence, and improve long-term patient outcomes

doi: 10.1111/dom.15728 39 LingeJBirkenfeldALNeelandIJ

Evaluation of safety and efficacy of add-on alpha-lipoic acid on migraine prophylaxis in an adolescent population: a randomized controlled trial

Hood JL, San RS, Wickline SA